Xilio Therapeutics, Inc. (XLO)
0.7103
-0.01
(-1.09%)
USD |
NASDAQ |
Dec 11, 16:00
0.7245
+0.01
(+2.00%)
After-Hours: 20:00
Xilio Therapeutics Total Assets (Quarterly): 133.69M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 58.53B |
| BioXcel Therapeutics, Inc. | 44.79M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
| Theriva Biologics, Inc. | 30.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 141.79M |
| Shareholders Equity (Quarterly) | -8.095M |
| Debt to Equity Ratio | -0.8972 |
| Current Ratio | 2.200 |
| Net Debt Paydown Yield | 0.65% |